Chemical Compound Sourcing & Procurement

Pipeline for identifying, sourcing, and purchasing chemical compounds from commercial vendors. Resolves compound identity through PubChem/ChEMBL, searches multiple vendor databases (ZINC, Enamine, eMolecules, Mcule), compares pricing and availability, and identifies purchasable analogs when exact compounds are unavailable.

Guiding principles:

1. Identity first -- confirm the compound's structure (SMILES, InChI) before searching vendors; names can be ambiguous
2. Multi-vendor comparison -- always check multiple sources; pricing and stock vary significantly
3. Analog fallback -- if the exact compound is unavailable, search for close analogs
4. Purity and quantity awareness -- note catalog purity grades and minimum order quantities
5. Structure over name -- vendor searches by SMILES/InChI are more reliable than name searches
6. English-first queries -- use English compound names in tool calls

LOOK UP, DON'T GUESS

When uncertain about any scientific fact, SEARCH databases first rather than reasoning from memory. A database-verified answer is always more reliable than a guess.

COMPUTE, DON'T DESCRIBE

When analysis requires computation (statistics, data processing, scoring, enrichment), write and run Python code via Bash. Don't describe what you would do — execute it and report actual results. Use ToolUniverse tools to retrieve data, then Python (pandas, scipy, statsmodels, matplotlib) to analyze it.

When to Use

Typical triggers:

• "Where can I buy [compound]?"
• "Find commercial sources for [SMILES]"
• "Compare prices for [compound] across vendors"
• "Is [compound] commercially available?"
• "Find purchasable analogs of [compound]"
• "I need [quantity] of [compound] -- who sells it?"
• "Search ZINC/Enamine for [compound]"

Not this skill: For ADMET/toxicity assessment, use tooluniverse-admet-prediction. For drug-target interaction analysis, use tooluniverse-drug-target-validation.

Core Databases

Workflow Overview

Phase 0: Compound Identity Resolution
  Name/SMILES/CAS -> PubChem CID -> canonical SMILES
    |
Phase 1: Vendor Search
  Query ZINC, Enamine, eMolecules, Mcule
    |
Phase 2: Price & Availability Comparison
  Catalog numbers, pricing, stock status, purity
    |
Phase 3: Analog Search (if needed)
  Similarity search for purchasable alternatives
    |
Phase 4: Bioactivity Context (optional)
  ChEMBL activity data for sourced compounds
    |
Phase 5: Order Summary
  Consolidated vendor comparison table

Phase Details

Phase 0: Compound Identity Resolution

Objective: Establish unambiguous compound identity before vendor searches.

Tools:

• PubChem_get_CID_by_compound_name -- resolve name to CID
• Input: name (compound name)
• Output: {IdentifierList: {CID: [...]}}
• PubChem_get_compound_properties_by_CID -- get SMILES, MW, formula
• Input: cid (PubChem CID), properties (comma-separated list)
• Output: {CID, MolecularWeight, ConnectivitySMILES, IUPACName}
• ChEMBL_get_molecule -- get ChEMBL compound details
• Input: molecule_chembl_id (ChEMBL ID) or search by name
• Output: SMILES, molecular properties, synonyms

Workflow:

1. If user provides a name: resolve to PubChem CID, then get SMILES
2. If user provides SMILES: use directly (optionally verify via PubChem)
3. If user provides CAS number: search PubChem by name (CAS numbers work as search terms)
4. Record: canonical SMILES, molecular weight, molecular formula, IUPAC name

Important: PubChem ConnectivitySMILES (not CanonicalSMILES) is the correct property name. Always confirm the SMILES matches the intended compound before proceeding.

Phase 1: Vendor Search

Objective: Search all available vendor databases for the target compound.

Tools:

• ZINC_search_compounds -- search ZINC by name or SMILES
• Input: query (name or SMILES), optional catalog, limit
• Output: ZINC IDs, vendor info, purchasability status
• ZINC_get_compound -- get detailed compound info from ZINC
• Input: zinc_id (ZINC identifier)
• Output: vendors, catalogs, pricing, SMILES
• Enamine_search_catalog -- search Enamine catalog
• Input: query (name or SMILES), optional catalog_type, limit
• Output: catalog numbers, availability, pricing
• Enamine_get_compound -- get Enamine compound details
• Input: compound_id (Enamine catalog number)
• Output: structure, pricing, stock status, delivery time
• eMolecules_search -- search across multiple vendors
• Input: query (name or SMILES), optional limit
• Output: vendor list, catalog numbers, pricing
• eMolecules_get_compound -- get eMolecules compound details
• Input: compound_id (eMolecules ID)
• Output: vendors, pricing tiers, purity
• Mcule_get_compound -- search Mcule database
• Input: query (name or SMILES), optional limit
• Output: Mcule IDs, availability, pricing
• Mcule_get_compound -- get Mcule compound details
• Input: compound_id (Mcule ID)
• Output: pricing, delivery, purity, catalog number

Workflow:

1. Search all four vendor databases in parallel using SMILES (preferred) or name
2. For each hit, retrieve detailed compound info (pricing, stock, purity)
3. Deduplicate results by matching SMILES across vendors
4. Flag any structural mismatches (vendor compound differs from target)

Tip: SMILES-based searches are more precise than name searches. If name search returns too many results, switch to SMILES.

Phase 2: Price & Availability Comparison

Objective: Create a comparison table across vendors.

Compile from Phase 1 results:

Rank vendors by: (1) in-stock availability, (2) price per mg, (3) purity grade, (4) delivery time.

Phase 3: Analog Search

Objective: When the exact compound is unavailable, find purchasable structural analogs.

Triggered when:

• No vendors carry the target compound
• The compound is prohibitively expensive
• The user explicitly requests analogs

Approach:

1. Use ZINC or Enamine similarity search (if supported by the tool's search mode)
2. Search by substructure using the compound's core scaffold SMILES
3. Filter analogs by: Tanimoto similarity >= 0.7, commercial availability, reasonable price
4. Present analogs with structural differences highlighted

Phase 4: Bioactivity Context (Optional)

Objective: Provide biological activity data for context when sourcing compounds for research.

Tools:

• ChEMBL_get_molecule -- get bioactivity summary
• Input: compound identifier
• Output: known targets, activity values, assay data

Useful when:

• User is sourcing compounds for a specific biological assay
• Comparing analogs that might have different activity profiles
• Verifying the compound has published bioactivity data

Phase 5: Decision & Order Summary

Vendor selection decision matrix — don't just list vendors, recommend one:

Red flags when sourcing:

• Vendor has no published purity data → request CoA before ordering
• Price is 10x lower than other vendors → may be a different salt form or impure
• "In stock" but delivery estimate is 4+ weeks → likely not actually in stock
• SMILES in vendor catalog differs from target SMILES → wrong compound

Generate a final sourcing report:

1. Compound Identity -- name, SMILES, MW, CAS (if known), PubChem CID
2. Vendor Comparison Table -- all vendors with pricing, stock, purity, delivery time
3. Recommended Source -- specific vendor with reasoning (not just cheapest)
4. Analogs (if searched) -- alternative compounds with similarity scores and bioactivity comparison
5. Notes -- special handling, storage conditions, salt form, stereochemistry considerations

Common Analysis Patterns

Edge Cases & Fallbacks

• Name ambiguity: Multiple compounds share a name (e.g., "aspirin" vs "acetylsalicylic acid"). Always resolve to SMILES first
• Stereochemistry: Vendors may sell racemic mixtures vs specific enantiomers. Check SMILES stereochemistry carefully
• Salt forms: The same drug may be sold as different salts (HCl, maleate, etc.). Note the specific form
• No vendors found: Compound may be available through custom synthesis. Note this in the report
• Make-on-demand: Enamine REAL compounds require synthesis (2-4 weeks). Distinguish from in-stock items

Interpretation Framework

Interpreting vendor results:

• A 10x price difference between vendors for the same compound usually indicates different salt forms, purity grades, or packaging sizes rather than genuine cost differences -- always compare on a per-mg, same-purity basis.
• Purity of >=95% is sufficient for primary screening; >=98% is recommended for dose-response and SAR studies; >=99% is needed for reference standards and pharmacokinetic work.
• "In-stock" status in aggregator databases can be stale by weeks -- confirm real-time availability with the vendor before committing to a timeline.

Synthesis questions to address in the final report:

1. Do all vendor SMILES resolve to the same canonical structure (including stereochemistry and salt form)?
2. Is the price-per-mg consistent with the compound's synthetic complexity, or does an outlier suggest a catalog error?
3. For analogs: does the structural change fall outside the pharmacophore, preserving expected activity?

Limitations

• Pricing accuracy: Database prices may be outdated; actual quotes from vendors are authoritative
• Regional availability: Some vendors ship only to specific regions; check shipping policies
• Quantity limits: Academic vs commercial pricing may differ; some vendors require institutional accounts
• Controlled substances: Some compounds have regulatory restrictions; this skill does not check legal status
• No direct ordering: This skill finds sources but does not place orders; users need vendor accounts